Variable | Tumor progression | Tumor-related death | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Breed predisposed to biologically aggressive cMCTs | 0.92 (0.16–5.4) | 0.925 | 0.39 (0.03–4.39) | 0.443 |
Age > 7 years | 4.02 (0.75–21.44) | 0.104 | 6.3 (0.57–69.79) | 0.133 |
Weight > 30.7 kg | 1.38 (0.25–7.71) | 0.714 | 0.99 (0.87–1.12) | 0.832 |
Male sex | 0.66 (0.12–3.62) | 0.634 | 0.7 (0.06–7.81) | 0.770 |
Neutering status | 0.42 (0.08–2.07) | 0.285 | 0.18 (0.02–2.01) | 0.163 |
Biologically aggressive anatomic location | 1.51 (0.18–13.01) | 0.705 | NA | |
Tumor diameter > 1.3 cm | 0.56 (0.10–3.09) | 0.510 | 2.41 (0.22–26.59) | 0.473 |
Ulceration | 2.71 (0.29–25.30) | 0.383 | NA | |
Patnaik grade 2 | 0.41 (0.05–3.59) | 0.421 | 0.35 (0.03–3.88) | 0.39 |
Lack of prophylactic regional lymphadenectomy | 43.02 (0.04–41,697.1) | 0.284 | 33.17 (0–1,727,740.46) | 0.527 |